Traitement et prise en charge de la cholangite sclérosante ... - Afef

REFERENCES1. Beuers U, Spengler U, Kruis W, Aydemir U, Wiebecke B, Heldwein W, et al. Ursodeoxycholic acidfor treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology 1992;16:707-714.2. Chazouillères O, Poupon R, Capron JP, Metman EH, Dhumeaux D, Amouretti M, et al.Ursodeoxycholic acid for primary sclerosing cholangitis. J Hepatol 1990; 11: 120-3.3. Lindor KD, for the Mayo Primary Sclerosing Cholangitis- Ursodeoxycholic acid Study Group.Ursodiol for primary sclerosing cholangitis. N Engl J Med 1997; 336: 691-5.4. Harnois DM, Angulo P, Jorgensen RA, Laruso NF, Lindor KD. High-dose ursodeoxycholic acid as atherapy for patients with primary sclerosing cholangitis. Am J Gastroenterol 2001;96:1558-62.5. Chazouillères O, Bonnand AM, Poupon R, Poupon RE, Groupe Français d’Etude de la CSP. Lacholangite sclérosante primitive en France : premières données de l’Observatoire National.Gastroenterol Clin Biol 2001;25:A80 (res).6. Tung BY, Emond MJ, Haggitt RC, Bronner MP, Kimmey MB, Kowdley KV, et al. Ursodiol use isassociated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primarysclerosing cholangitis. Ann Intern Med 2001;134:89-95.7. Schramm C, Schirmacher P, Helmreich-Becker I, Gerken G, Zum Buschenfelde KH, Lohse AW.Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosingcholangitis. A case series. Ann Intern Med 1999;131:943-6.8. Abrendt SA, Pitt HA, Nakeeb A, Klein AS, Lillemoe KD, Kalloo AN, Cameron JL. Diagnosis andmanagement of cholangiocarcinoma in primary sclerosing cholangitis. J Gastrointest Surg1999;3:357-368.9. Ponsioen CY, Vrouenraets SME, van Milligen de Wit AWM, Sturm P, Tascilar M, Offerhaus GJA,Prins M, Huibregtse K, Tytgat GNJ. Endoscopy 1999;31:305-309.